Hepatitis is the disease characterized by the inflammation of the liver. Hepatitis mainly occur due to the viral infections, heavy alcohol intake, consumption of hepatotoxic drugs, blood transfusions and autoimmune diseases among others. Hepatitis is classified as hepatitis A, B, C, D, E in which hepatitis A, B, C mostly occurs in humans. The symptoms associated with hepatitis include poor appetite, whites of eyes, discoloration of skin, vomiting, abdominal pain, and diarrhoea among others. Hepatitis can be prevented by the administration of vaccines in newborn babies.
Some of the players in the global hepatitis treatment market include:
Hoffmann- La Roche Ltd. (Switzerland), Gilead Sciences (U.S.), Novartis AG (Switzerland), Bristol-Myers Squibb (U.S), GlaxoSmithKline, plc., Merck and Co, Inc. (U.S), Johnson & Johnson Services, Inc. (U.S.), AbbVie Inc. (U.S.), Novira Therapeutics Inc. (U.S.), Eiger Biopharmaceuticals (U.S.)
No comments:
Post a Comment